Profound Medical earnings were -$18.1M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest PROF earnings report on Jun 30, 2024 announced Q2 2024 earnings of -$3.5M, up 386.4% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, PROF reported annual earnings of -$25.1M, with 107.4% growth. The next PROF earnings date is Oct 31, 2024.
What were Profound Medical's earnings last quarter?
On PROF's earnings call on Invalid Date, Profound Medical (NASDAQ: PROF) reported Q2 2024 earnings per share (EPS) of -$0.20, up 22.43% year over year. Total PROF earnings for the quarter were -$3.54 million. In the same quarter last year, Profound Medical's earnings per share (EPS) was -$0.26.
The next PROF earnings call is Invalid Date. Add PROF to your watchlist to be reminded of Profound Medical's next earnings date.
Is Profound Medical profitable or losing money?
As of the last Profound Medical earnings report, Profound Medical is currently losing money. Profound Medical's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$18.34 million, a 17.85% increase year over year.
What was PROF's earnings growth in the past year?
As of Profound Medical's earnings date in Invalid Date, Profound Medical's earnings has grown year over year. PROF earnings in the past year totalled -$18.07 million.
What are Profound Medical's earnings expectations?
The current EPS estimate for Profound Medical's earnings report in Invalid Date is -$0.30.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.